BC Innovations | Feb 19, 2015
Distillery Therapeutics

Therapeutics: Kallikrein-related peptidase 5 (KLK5); KLK7; KLK14; suppression of tumorigenicity 14 (ST14; matriptase)

Dermatology INDICATION: Dermatology In vitro and mouse studies have identified coumarin-3-carboxylate-based protease inhibitors that could help treat skin diseases such as Netherton syndrome, which is characterized by high levels of Kallikrein-related protease activity in the...
BC Innovations | Mar 13, 2014
Distillery Techniques

Technology: Disease models

Approach Summary Licensing status Publication and contact information Disease models Transgenic mouse models of Netherton syndrome expressing human kallikrein-related peptidase 5 (KLK5) Transgenic mice expressing human KLK5 in the epidermis could be used to study...
Items per page:
1 - 2 of 2